Teva-Gliclazide · DIN 02238103 · 80 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Teva-Gliclazide · DIN 02238103
Manufacturer: Teva Canada Limited; listing date 2007-06-06
Health Canada: Marketed since 2014-02-11 · brand TEVA-GLICLAZIDE · ATC A10BB09 GLICLAZIDE · form Tablet · route Oral · ingredients GLICLAZIDE 80 MG · company Teva canada limited · schedule Prescription
Teva-Gliclazide: Formulary list price $0.09 per unit (the source does not state the unit; exact figure $0.0931). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02238103)
Source record
DIN 02238103: Teva-Gliclazide
Raw flags: chronicUseMed=Y, insOH=Y, sec3=Y
Item: 682002010; group id 745; item number 1825; lccId None; manufacturer id TEV
Source form: Tab; strength: 80mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit); diabetes medication flag
Source prices (unrounded): $0.0931; ministry $0.0931
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02238103
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=61497
Interchangeable products
Apo-Gliclazide · DIN 02245247 · $0.0931
Diamicron · DIN 00765996 · not recorded
Gliclazide · DIN 02287072 · $0.0931
Shortage status: not checked (no credentials)